Atara Biotherapeutics Inc (ATRA) Insider Trading
- $3,819,989.71
- $54,474,671.30
- Nov. 18, 2024
- Isaac E Ciechanover
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 10, 2017 | CFO | 24,000 | $20.00 | Sell | $480,000.00 | |
March 10, 2017 | EVP | 2,500 | $20.00 | Sell | $50,000.00 | |
Feb. 21, 2017 | CFO | 9,000 | $15.14 | Sell | $136,260.00 | |
Feb. 16, 2017 | CEO | 4,800 | $15.56 | Sell | $74,688.00 | |
Feb. 16, 2017 | Director | 1,183 | $16.10 | Sell | $19,046.30 | |
Feb. 16, 2017 | EVP | 3,059 | $15.96 | Sell | $48,821.64 | |
Feb. 15, 2017 | EVP | 7,604 | $15.49 | Sell | $117,785.96 | |
Feb. 10, 2017 | EVP | 6,274 | $15.47 | Sell | $97,058.78 | |
Feb. 9, 2017 | EVP | 13,975 | $15.46 | Sell | $216,053.50 | |
Feb. 3, 2017 | CEO | 4,800 | $13.66 | Sell | $65,568.00 | |
Jan. 18, 2017 | CEO | 6,000 | $14.24 | Sell | $85,440.00 | |
Jan. 17, 2017 | EVP | 6,000 | $14.27 | Sell | $85,620.00 | |
Jan. 6, 2017 | CEO | 8,400 | $16.89 | Sell | $141,876.00 | |
Dec. 23, 2016 | CEO | 4,800 | $15.22 | Sell | $73,056.00 | |
Dec. 15, 2016 | Insider | 6,000 | $15.40 | Sell | $92,400.00 | |
Dec. 7, 2016 | CEO | 7,200 | $17.93 | Sell | $129,096.00 | |
Nov. 23, 2016 | CEO | 12,000 | $18.34 | Sell | $220,080.00 | |
Nov. 22, 2016 | CEO | 8,400 | $18.21 | Sell | $152,964.00 | |
Nov. 16, 2016 | Director | 1,184 | $19.35 | Sell | $22,910.40 | |
Nov. 16, 2016 | COO | 16,718 | $20.00 | Sell | $334,360.00 | |
Nov. 16, 2016 | Insider | 2,995 | $19.53 | Sell | $58,492.35 | |
Nov. 14, 2016 | COO | 9,582 | $20.55 | Sell | $196,910.10 | |
Nov. 11, 2016 | CFO | 5,000 | $19.84 | Sell | $99,200.00 | |
Oct. 27, 2016 | CEO | 4,800 | $13.81 | Sell | $66,288.00 | |
Oct. 14, 2016 | CEO | 4,800 | $15.96 | Sell | $76,608.00 | |
Oct. 12, 2016 | CFO | 5,000 | $17.47 | Sell | $87,350.00 | |
Sept. 28, 2016 | CEO | 12,000 | $20.87 | Sell | $250,440.00 | |
Sept. 16, 2016 | CEO | 7,200 | $19.36 | Sell | $139,392.00 | |
Aug. 23, 2016 | CEO | 9,600 | $22.33 | Sell | $214,368.00 | |
Aug. 16, 2016 | COO | 5,356 | $22.41 | Sell | $120,027.96 | |
Aug. 15, 2016 | Insider | 1,346 | $22.32 | Sell | $30,042.72 | |
July 21, 2016 | CEO | 9,600 | $22.11 | Sell | $212,256.00 | |
July 8, 2016 | CEO | 9,600 | $22.88 | Sell | $219,648.00 | |
June 24, 2016 | CEO | 9,600 | $21.26 | Sell | $204,096.00 | |
June 8, 2016 | CEO | 12,000 | $20.53 | Sell | $246,360.00 | |
June 7, 2016 | CEO | 7,200 | $20.36 | Sell | $146,592.00 | |
May 26, 2016 | CEO | 7,200 | $17.69 | Sell | $127,368.00 | |
May 18, 2016 | Director | 1,184 | $15.96 | Sell | $18,896.64 | |
May 17, 2016 | COO | 5,427 | $15.91 | Sell | $86,343.57 | |
May 16, 2016 | CFO | 5,395 | $15.77 | Sell | $85,079.15 | |
May 16, 2016 | Insider | 4,153 | $15.15 | Sell | $62,917.95 | |
April 26, 2016 | CEO | 1,300 | $20.12 | Sell | $26,156.00 | |
April 12, 2016 | CEO | 13,210 | $20.40 | Sell | $269,484.00 | |
April 1, 2016 | CEO | 1,190 | $20.03 | Sell | $23,835.70 | |
March 17, 2016 | Director | 3,000 | $13.86 | Buy | $41,580.00 | |
Feb. 17, 2016 | Director | 1,183 | $16.30 | Sell | $19,282.90 | |
Feb. 17, 2016 | COO | 5,711 | $16.77 | Sell | $95,773.47 | |
Jan. 14, 2016 | CEO | 2,400 | $20.20 | Sell | $48,480.00 | |
Dec. 31, 2015 | CEO | 2,400 | $26.00 | Sell | $62,400.00 | |
Dec. 16, 2015 | Director | 2,500 | $22.00 | Buy | $55,000.00 |
Insiders are both buying and selling Atara Biotherapeutics Inc stock.
The insider traders at Atara Biotherapeutics Inc are: Isaac E Ciechanover, Joe Newell, Christopher Haqq, Carol Giltner Gallagher, John Mcgrath, Pascal Touchon, Utpal Koppikar, Gad Soffer, Amar Murugan, Jakob Dupont, Eric J Hyllengren, Mitchall G Clark, Anhco Nguyen, Derrell Porter, Joel S Marcus, Eric Dobmeier, Kristin Yarema, Matthew K Fust, Mitchall G. Clark, Jill Henrich, Heather D Turner, William K Heiden, Domain Partners Viii, L.P., and Isaac E. Ciechanover
The most active insider trader at Atara Biotherapeutics Inc is Isaac E Ciechanover with 102 trades.
Isaac E Ciechanover has sold the most Atara Biotherapeutics Inc stock with a total value of $26,010,505.70.
Domain Partners Viii, L.P. has bought the most Atara Biotherapeutics Inc stock with a total value of $5,459,498.00.
The most recent insider trade for Atara Biotherapeutics Inc was on Nov. 18, 2024.
The single biggest insider buy for Atara Biotherapeutics Inc was from Domain Partners Viii, L.P. with a total value of $2,729,749.00 on Oct. 21, 2014.
The single biggest insider sell for Atara Biotherapeutics Inc was from Isaac E Ciechanover with a total value of $2,336,000.00 on July 10, 2018.